Logo-ps

 

 

 

Follower of ICMJE

Powered by:
Pharm Sci. 2020;26(Covid-19): S49-S51. doi: 10.34172/PS.2020.41

Mini Review

NSAIDs and COVID-19: A New Challenging Area

Hananeh Baradaran 1 ORCID, Hadi Hamishehkar 2, Haleh Rezaee 2 * ORCID

Cited by CrossRef: 5

1- Ghanavati M, Tadayon F, Basiryanmahabadi A, Torabi Fard N, Smiley E. Design of new sensing layer based on ZnO/NiO/Fe3O4/MWCNTs nanocomposite for simultaneous electrochemical determination of Naproxen and Sumatriptan. Journal of Pharmaceutical and Biomedical Analysis. 2023;223:115091 [Crossref]
2- Kiani P, Scholey A, Dahl T, McMann L, Iversen J, Verster J. In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2. Viruses. 2021;13(4):558 [Crossref]
3- Pourkarim F, Pourtaghi‐Anvarian S, Rezaee H. Molnupiravir: A new candidate for COVID‐19 treatment. Pharmacology Res & Perspec. 2022;10(1) [Crossref]
4- Mohamed S, El Bakri Y, Abdul D, Ahmad S, Albayati M, Lai C, Mague J, Tolba M. Synthesis, crystal structure, and a molecular modeling approach to identify effective antiviral hydrazide derivative against the main protease of SARS-CoV-2. Journal of Molecular Structure. 2022;1265:133391 [Crossref]
5- Esalatmanesh K, Azadbakht J, Hajialilo M, Soroush M, Esalatmanesh R, Soleimani Z, Khabbazi A. Clinical course, chest computed tomography severity score and outcome of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases. The Egyptian Rheumatologist. 2022;44(3):245 [Crossref]

   Indexing & Abstracting: